Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Recruiting 1Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1Gastrointestinal 1CNS 1Breast 1

Conditions

Breast Neoplasms 5Prostatic Neoplasms 3Urogenital Neoplasms 2Pancreatic Neoplasms 2Endometrial Neoplasms 2Colorectal Neoplasms, Hereditary Nonpolyposis 2Colorectal Neoplasms 2Brain Neoplasms 2Women Age 35+ Qualifies if >15% Lifetime Risk of Breast Cancer as Defined by IBIS Version 8 1Wilms Tumor 1Rectal Neoplasms 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Ovarian Neoplasms 1Neurofibromatosis 1 1Neoplasms, Unknown Primary 1Neoplasm Metastasis 1Kidney Neoplasms 1Hot Flashes 1Head and Neck Neoplasms 1Genetic Predisposition to Disease 1Dyslexia 1Digestive System Neoplasms 1Depression 1Colonic Neoplasms 1Central Nervous System Neoplasms 1Advanced Malignant Neoplasm 1

Interventions

Carboplatin 8Paclitaxel 7Gemcitabine 7Irinotecan 6Radiotherapy 4Oxaliplatin 4Capecitabine 4Leucovorin 3Fluorouracil 3Filgrastim 3Erlotinib Hydrochloride 3Cisplatin 3Bevacizumab 3etoposide phosphate 2Trastuzumab 2Surveys and Questionnaires 2Peripheral Blood Stem Cell Transplantation 2Etoposide 2Amifostine 2Albumin-Bound Paclitaxel 2tipifarnib 1tegafur-gimeracil-oteracil 1sintilimab 1pertuzumab 1pemigatinib 1pembrolizumab 1olaparib 1ivosidenib 1ipatasertib 1erythromycin propionate-N-acetylcysteinate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Neoplasms, Unknown Primary × Genetic Testing × Clear all
NCT04456140 2023-07-24

Pro-Active Genetic Testing in Patients With Solid Tumors, Inherit Study

Mayo Clinic

Phase 1 Completed
230 enrolled
BreastCNSGastrointestinalHead & Neck

Brain Neoplasms, Breast Neoplasms, Digestive System Neoplasms, Head and Neck Neoplasms, Neoplasms, Unknown Primary, Urogenital Neoplasms, Central Nervous System Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡